A股绝地反击！创新药爆发，港股通创新药ETF放量上探3.37%强势领跑！生猪价格显著回升，农牧渔ETF收涨超1%

Market Overview - The A-share market experienced a significant reversal on November 3, with all three major indices closing in the green. The Shanghai Composite Index rose by 0.55%, the Shenzhen Component Index increased by 0.19%, and the ChiNext Index gained 0.29%. The total trading volume exceeded 2.1 trillion yuan [1] Sector Performance Innovative Drugs - The innovative drug sector continued to thrive, with the high-volatility Hong Kong Stock Connect Innovative Drug ETF (520880) closing up by 2.13%, leading the market in the pharmaceutical ETF category. The ETF saw a trading volume of 866 million yuan, marking a new high since September 12 [1][3] - The ETF covers 37 innovative drug companies, with 33 stocks closing in the green. Notable performers included Shengxian Pharmaceutical, which surged by 7.36%, and other companies like Kangnuo Pharmaceutical and Yuan Da Pharmaceutical, which rose over 6% [4] Banking Sector - The banking sector showed resilience, with the top-tier Bank ETF (512800) rising by 1.23%, recovering both the 5-day and 10-day moving averages. The sector's performance was bolstered by a stable net interest margin and increased holdings from insurance companies [1][11] - The overall banking index rose by 1.31%, with 40 out of 42 listed banks reporting gains. Major banks like China Construction Bank and China Merchants Bank saw increases of over 2% [8][9] Agriculture, Animal Husbandry, and Fisheries - The agriculture, animal husbandry, and fisheries sector exhibited strong performance, with the only agricultural ETF (159275) closing up by 1.21%. The rise was attributed to a significant rebound in pig prices, which increased by 6.1% from the previous week [1][13] - Key stocks in this sector included Zhongxing Junye and Luoniushan, both of which hit the daily limit, while Hainan Rubber surged by 5.67% [13] Future Outlook - Analysts from Guosen Securities noted that the A-share market is currently supported by multiple favorable factors, including the "14th Five-Year Plan" providing clear investment pathways and a reduction in overseas disturbances, which has improved market risk appetite [3] - The banking sector is expected to benefit from a shift in market style, with a focus on low-value stocks, while the innovative drug sector may transition towards a phase driven by fundamental improvements rather than just capital inflows [5][12]